July 29, 2021

Global Govt-19 death toll exceeds 4 million

In all, three countries account for one-third of all deaths worldwide. The United States has the highest death toll at 606,000, followed by Brazil and India at 15% worldwide.

Delta variant, The most contagious and most dangerous strain of the corona virus, contributes to the increase in cases in some countries and regions. In the United States, the delta variant is now evolving More than half of all new infections, According to estimates by the U.S. Centers for Disease Control and Prevention (CDC).

The JHU reports that an average of 7,900 Govt-19 deaths were reported each day last week. This is 46% lower than the global peak of more than 14,700 daily deaths in January, but 57% higher than the speed of 5,000 daily deaths over this time last year.

World death toll rises to 1 million on September 18, 2020, 191 days after the World Health Organization announced Corona virus outbreak novel Global epidemic. The global death toll rose to 2 million, 88 days to exceed 3 million, and 115 days to 89 days to reach 4 million.

Given the difficulty in accurately detecting the spread of the virus, especially in developing countries, many experts believe that the global death toll could be significantly higher than the officially announced number.

In a statement on Thursday, United Nations Secretary-General Antonio Guterres warned that the epidemic was “far away” and warned of more contagious, more deadly variants that could undermine the effectiveness of current vaccines if the virus is allowed. To continue to spread.

“Vaccines offer a ray of hope – but much of the world is still in the shadows. The virus is more than just vaccine distribution,” he said, calling for a global plan to increase vaccine production, ensure equitable distribution and tackle vaccine reluctance.

“To realize this plan, I call on the Emergency Task Force to unite all countries with vaccine production potential, the World Health Organization, the Global Vaccine Alliance GAVI and related international financial institutions that can deal with pharmaceutical companies and manufacturers, and other key stakeholders,” he said.